MATRIX SERVICE CO (MTRX) Fundamental Analysis & Valuation

NASDAQ:MTRX • US5768531056

Current stock price

11.98 USD
-0.15 (-1.24%)
At close:
11.98 USD
0 (0%)
After Hours:

This MTRX fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

1

1. MTRX Profitability Analysis

1.1 Basic Checks

  • MTRX had negative earnings in the past year.
  • MTRX had a positive operating cash flow in the past year.
  • In the past 5 years MTRX always reported negative net income.
  • In multiple years MTRX reported negative operating cash flow during the last 5 years.
MTRX Yearly Net Income VS EBIT VS OCF VS FCFMTRX Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 50M -50M 100M

1.2 Ratios

  • The Return On Assets of MTRX (-2.96%) is worse than 76.36% of its industry peers.
  • MTRX's Return On Equity of -14.00% is on the low side compared to the rest of the industry. MTRX is outperformed by 76.36% of its industry peers.
Industry RankSector Rank
ROA -2.96%
ROE -14%
ROIC N/A
ROA(3y)-7.84%
ROA(5y)-8.94%
ROE(3y)-21.58%
ROE(5y)-20.74%
ROIC(3y)N/A
ROIC(5y)N/A
MTRX Yearly ROA, ROE, ROICMTRX Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 10 -10 -20

1.3 Margins

  • MTRX's Gross Margin of 5.76% is on the low side compared to the rest of the industry. MTRX is outperformed by 85.45% of its industry peers.
  • MTRX's Gross Margin has declined in the last couple of years.
  • The Profit Margin and Operating Margin are not available for MTRX so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 5.76%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5Y-11.09%
MTRX Yearly Profit, Operating, Gross MarginsMTRX Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 5 -5

4

2. MTRX Health Analysis

2.1 Basic Checks

  • MTRX does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • The number of shares outstanding for MTRX has been increased compared to 1 year ago.
  • MTRX has more shares outstanding than it did 5 years ago.
  • There is no outstanding debt for MTRX. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
MTRX Yearly Shares OutstandingMTRX Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5M 10M 15M 20M 25M
MTRX Yearly Total Debt VS Total AssetsMTRX Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M

2.2 Solvency

  • Based on the Altman-Z score of 1.51, we must say that MTRX is in the distress zone and has some risk of bankruptcy.
  • Looking at the Altman-Z score, with a value of 1.51, MTRX is doing worse than 78.18% of the companies in the same industry.
  • MTRX has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 1.51
ROIC/WACCN/A
WACC9.92%
MTRX Yearly LT Debt VS Equity VS FCFMTRX Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 100M 200M 300M

2.3 Liquidity

  • A Current Ratio of 0.91 indicates that MTRX may have some problems paying its short term obligations.
  • MTRX has a worse Current ratio (0.91) than 81.82% of its industry peers.
  • MTRX has a Quick Ratio of 0.91. This is a bad value and indicates that MTRX is not financially healthy enough and could expect problems in meeting its short term obligations.
  • MTRX has a Quick ratio of 0.89. This is amonst the worse of the industry: MTRX underperforms 80.00% of its industry peers.
Industry RankSector Rank
Current Ratio 0.91
Quick Ratio 0.89
MTRX Yearly Current Assets VS Current LiabilitesMTRX Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M 400M

4

3. MTRX Growth Analysis

3.1 Past

  • The Earnings Per Share has grown by an impressive 64.17% over the past year.
  • MTRX shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 18.45%.
  • The Revenue has been decreasing by -6.92% on average over the past years.
EPS 1Y (TTM)64.17%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%90%
Revenue 1Y (TTM)18.45%
Revenue growth 3Y2.82%
Revenue growth 5Y-6.92%
Sales Q2Q%12.47%

3.2 Future

  • MTRX is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 23.06% yearly.
  • MTRX is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 5.65% yearly.
EPS Next Y119.74%
EPS Next 2Y73.15%
EPS Next 3Y39.09%
EPS Next 5Y23.06%
Revenue Next Year14.15%
Revenue Next 2Y11.72%
Revenue Next 3Y7.46%
Revenue Next 5Y5.65%

3.3 Evolution

  • The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
MTRX Yearly Revenue VS EstimatesMTRX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 500M 1B
MTRX Yearly EPS VS EstimatesMTRX Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 0 1 -1

5

4. MTRX Valuation Analysis

4.1 Price/Earnings Ratio

  • MTRX reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
  • Based on the Price/Forward Earnings ratio of 12.91, the valuation of MTRX can be described as correct.
  • Compared to the rest of the industry, the Price/Forward Earnings ratio of MTRX indicates a rather cheap valuation: MTRX is cheaper than 96.36% of the companies listed in the same industry.
  • MTRX is valuated cheaply when we compare the Price/Forward Earnings ratio to 38.20, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE N/A
Fwd PE 12.91
MTRX Price Earnings VS Forward Price EarningsMTRX Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 -20 40

4.2 Price Multiples

  • Compared to the rest of the industry, the Price/Free Cash Flow ratio of MTRX indicates a rather cheap valuation: MTRX is cheaper than 96.36% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 7.41
EV/EBITDA N/A
MTRX Per share dataMTRX EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 20

4.3 Compensation for Growth

  • MTRX's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • A more expensive valuation may be justified as MTRX's earnings are expected to grow with 39.09% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y73.15%
EPS Next 3Y39.09%

0

5. MTRX Dividend Analysis

5.1 Amount

  • No dividends for MTRX!.
Industry RankSector Rank
Dividend Yield 0%

MTRX Fundamentals: All Metrics, Ratios and Statistics

MATRIX SERVICE CO

NASDAQ:MTRX (4/16/2026, 4:01:16 PM)

After market: 11.98 0 (0%)

11.98

-0.15 (-1.24%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryConstruction & Engineering
Earnings (Last)02-04
Earnings (Next)05-05
Inst Owners88.38%
Inst Owner Change0.12%
Ins Owners4.58%
Ins Owner Change0.79%
Market Cap337.00M
Revenue(TTM)838.93M
Net Income(TTM)-19.26M
Analysts82.5
Price Target20.4 (70.28%)
Short Float %1.75%
Short Ratio1.5
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-153.77%
Min EPS beat(2)-158.53%
Max EPS beat(2)-149.02%
EPS beat(4)0
Avg EPS beat(4)-592.64%
Min EPS beat(4)-1930.07%
Max EPS beat(4)-132.96%
EPS beat(8)2
Avg EPS beat(8)-329.03%
EPS beat(12)3
Avg EPS beat(12)-238.45%
EPS beat(16)4
Avg EPS beat(16)-216.48%
Revenue beat(2)1
Avg Revenue beat(2)-1.84%
Min Revenue beat(2)-4.2%
Max Revenue beat(2)0.52%
Revenue beat(4)1
Avg Revenue beat(4)-5.27%
Min Revenue beat(4)-8.75%
Max Revenue beat(4)0.52%
Revenue beat(8)1
Avg Revenue beat(8)-6.41%
Revenue beat(12)1
Avg Revenue beat(12)-6.51%
Revenue beat(16)4
Avg Revenue beat(16)-4.53%
PT rev (1m)5.26%
PT rev (3m)21.21%
EPS NQ rev (1m)-33.01%
EPS NQ rev (3m)-44.88%
EPS NY rev (1m)-29.96%
EPS NY rev (3m)-44.7%
Revenue NQ rev (1m)0.35%
Revenue NQ rev (3m)-0.99%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-1.33%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 12.91
P/S 0.4
P/FCF 7.41
P/OCF 6.3
P/B 2.45
P/tB 3.11
EV/EBITDA N/A
EPS(TTM)-0.43
EYN/A
EPS(NY)0.93
Fwd EY7.75%
FCF(TTM)1.62
FCFY13.5%
OCF(TTM)1.9
OCFY15.88%
SpS29.82
BVpS4.89
TBVpS3.86
PEG (NY)N/A
PEG (5Y)N/A
Graham Number0 (-100%)
Profitability
Industry RankSector Rank
ROA -2.96%
ROE -14%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 5.76%
FCFM 5.42%
ROA(3y)-7.84%
ROA(5y)-8.94%
ROE(3y)-21.58%
ROE(5y)-20.74%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5Y-11.09%
F-Score5
Asset Turnover1.29
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA N/A
Cap/Depr 82.78%
Cap/Sales 0.96%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.91
Quick Ratio 0.89
Altman-Z 1.51
F-Score5
WACC9.92%
ROIC/WACCN/A
Cap/Depr(3y)68.67%
Cap/Depr(5y)50.47%
Cap/Sales(3y)1.03%
Cap/Sales(5y)0.84%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)64.17%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%90%
EPS Next Y119.74%
EPS Next 2Y73.15%
EPS Next 3Y39.09%
EPS Next 5Y23.06%
Revenue 1Y (TTM)18.45%
Revenue growth 3Y2.82%
Revenue growth 5Y-6.92%
Sales Q2Q%12.47%
Revenue Next Year14.15%
Revenue Next 2Y11.72%
Revenue Next 3Y7.46%
Revenue Next 5Y5.65%
EBIT growth 1Y49.24%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year157.5%
EBIT Next 3Y52.65%
EBIT Next 5Y30.32%
FCF growth 1Y111.22%
FCF growth 3YN/A
FCF growth 5Y33.85%
OCF growth 1Y87.3%
OCF growth 3YN/A
OCF growth 5Y21.65%

MATRIX SERVICE CO / MTRX Fundamental Analysis FAQ

Can you provide the ChartMill fundamental rating for MATRIX SERVICE CO?

ChartMill assigns a fundamental rating of 3 / 10 to MTRX.


What is the valuation status of MATRIX SERVICE CO (MTRX) stock?

ChartMill assigns a valuation rating of 5 / 10 to MATRIX SERVICE CO (MTRX). This can be considered as Fairly Valued.


How profitable is MATRIX SERVICE CO (MTRX) stock?

MATRIX SERVICE CO (MTRX) has a profitability rating of 1 / 10.


How financially healthy is MATRIX SERVICE CO?

The financial health rating of MATRIX SERVICE CO (MTRX) is 4 / 10.


Can you provide the expected EPS growth for MTRX stock?

The Earnings per Share (EPS) of MATRIX SERVICE CO (MTRX) is expected to grow by 119.74% in the next year.